首页|山西省2015-2022年某医院血流感染耐碳青霉烯肺炎克雷伯菌检测及分析

山西省2015-2022年某医院血流感染耐碳青霉烯肺炎克雷伯菌检测及分析

扫码查看
目的 通过研究山西白求恩医院2015年1月—2022年1月血流感染患者血培养分离耐碳青霉烯肺炎克雷伯菌,总结其流行病学和分子生物学特点。方法 收集山西白求恩医院2015年1月—2022年1月血流感染患者血培养分离肺炎克雷伯菌为研究对象,进行细菌鉴定,药敏试验、改良碳青霉烯灭活试验筛选耐碳青霉烯肺炎克雷伯菌。对所有菌株进行二代测序并分析,其中2株拉丝实验阳性耐碳青霉烯高毒力肺炎克雷伯菌进行全基因组测序。结果 山西白求恩医院2015年1月—2022年1月血流感染患者血培养分离肺炎克雷伯菌共431株,耐碳青霉烯肺炎克雷伯菌共33株,其中耐碳青霉烯高毒力肺炎克雷伯菌11株,其中拉丝实验阳性2株。所有菌株对厄他培南、亚胺培南均耐药,仅1株对美罗培南中介。33株耐碳青霉烯肺炎克雷伯菌中26株产KPC-2、4株产NDM-1;有3株双酶型耐碳青霉烯高毒力肺炎克雷伯菌(KPC-2/NDM-9、KPC-2/OXA-1、NDM-1/OXA-1);4株未检测到碳青霉烯耐药基因。二代测序后进化分析结果显示33株耐碳青霉烯肺炎克雷伯菌主要序列类型(sequence types,ST)型别为ST11、ST147、ST412,主要血清型为KL64、KL47、KL25。质粒接合转移实验有18株转移成功。2株拉丝实验阳性菌株经全基因组测序发现携带毒力质粒和耐药质粒。结论 本院血流感染患者检出耐碳青霉烯肺炎克雷伯菌从2015年逐年增加,2021年出现暴发流行。携带的碳青霉烯酶基因以KPC-2为主,ST11/KL64型菌株占多数。进一步加强临床耐药菌株筛检及控制对临床抗感染治疗作用关键。
Clinical laboratory study of carbapenem-resistant Klebsiella pneumoniae bloodstream infections at a hospital in Shanxi Province from 2015 to 2022
Objective To investigate the epidemiological and molecular characteristics of carbapenem-resistant Klebsiella pneumoniae isolated from blood cultures of patients with bloodstream infections in Shanxi Bethune Hospital from January 2015 to January 2022.Methods Klebsiella pneumoniae strains isolated from blood cultures of patients with bloodstream infections at Shanxi Bethune Hospital from January 2015 to January 2022 were collected for the study.Bacterial identification,drug sensitivity testing,and an improved carbapenem inactivation test were conducted to screen for carbapenem-resistant Klebsiella pneumoniae.Next-generation sequencing was performed on all strains,while whole genome sequencing was carried out on two strains that tested positive for the modified Hodge test indicating resistance to carbapenems.Results A total of 431 strains of Klebsiella pneumoniae were isolated from blood cultures of patients with bloodstream infections at Shanxi Bethune Hospital between January 2015 to January 2022,among which 33 were carbapenem-resistant strains including 11 highly virulent ones and 2 of these exhibited positive for the modified Hodge test.All strains were resistant to both ertapenem and imipenem,with only one strain being intermediate-resistant to meropenem.Among the 33 resistant strains,KPC-2 was detected in 26 strains and NDM-1 in 4;three strains possessed dual carbapenemase types(KPC-2/NDM-9,KPC-2/OXA-1,NDM-1/OXA-1),while four did not show any detectable carbapenem-resistance genes.Evolutionary analysis following next-generation sequencing revealed that the main sequence types(ST)among these isolates were ST11,ST147,and ST412;and the predominant serotypes were KL64,KL47,and KL25.The plasmid conjugal transfer experiments were successful in 18 strains.The two high virulence strains identified in the modified Hodge test were found to carry virulence and resistance plasmids upon whole genome sequencing.Conclusions The detection of carbapenem-resistant Klebsiella pneumoniae in patients with bloodstream infections has been increasing annually since 2015,with an outbreak occurring in 2021.The carbapenemase KPC-2 gene was the most prevalent,with the majority of strains being of the ST11/KL64 type.Strengthening screening and control measures for clinical drug-resistant strains is crucial for effective anti-infective treatment.

Bloodstream infectionKlebsiella pneumoniaecarbapenemasedrug resistancevirulence

侯辰蕊、李亚楠、栗子洋、李霞、张晓慧、高春艳

展开 >

山西白求恩医院(山西医学科学院,同济山西医院),山西医科大学第三医院检验科,山西 太原 030032

血流感染 肺炎克雷伯菌 碳青霉烯酶 耐药性 毒力

山西省基础研究计划山西白求恩医院科研项目

20210321246032021YJ16

2024

中国热带医学
中华预防医学会,海南疾病预防控制中心

中国热带医学

CSTPCD北大核心
影响因子:0.722
ISSN:1009-9727
年,卷(期):2024.24(6)
  • 25